Sara D Spiva, DO | |
411 10th St Se Ste 150, Cedar Rapids, IA 52403-2449 | |
(319) 384-7222 | |
Not Available |
Full Name | Sara D Spiva |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 10 Years |
Location | 411 10th St Se Ste 150, Cedar Rapids, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053727487 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | DO-04788 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
St Lukes Hospital | Cedar rapids, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
State University Of Iowa | 7618884230 | 1476 |
News Archive
There is a lack of data relating to the risk of HIV transmission from contaminated injections, and this has made it difficult to assess their impact on HIV transmission in the region.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.
A new study finds that environmental factors and human mobility predict seasonal changes in COVID-19 rates, just as in influenza and similar diseases.
In a new development China has lifted its decades old reservations towards travelers and tourists suffering from HIV and AIDS in the wake of the Shanghai World Expo this weekend.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.
› Verified 2 days ago
Entity Name | State University Of Iowa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
There is a lack of data relating to the risk of HIV transmission from contaminated injections, and this has made it difficult to assess their impact on HIV transmission in the region.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.
A new study finds that environmental factors and human mobility predict seasonal changes in COVID-19 rates, just as in influenza and similar diseases.
In a new development China has lifted its decades old reservations towards travelers and tourists suffering from HIV and AIDS in the wake of the Shanghai World Expo this weekend.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Sara D Spiva, DO 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-7222 | Sara D Spiva, DO 411 10th St Se Ste 150, Cedar Rapids, IA 52403-2449 Ph: (319) 384-7222 |
News Archive
There is a lack of data relating to the risk of HIV transmission from contaminated injections, and this has made it difficult to assess their impact on HIV transmission in the region.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.
A new study finds that environmental factors and human mobility predict seasonal changes in COVID-19 rates, just as in influenza and similar diseases.
In a new development China has lifted its decades old reservations towards travelers and tourists suffering from HIV and AIDS in the wake of the Shanghai World Expo this weekend.
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.
› Verified 2 days ago
Dr. Sameer Bharat Nathoo, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 3rd Ave Se, Cedar Rapids, IA 52403 Phone: 319-730-7300 Fax: 319-369-7494 | |
Dr. Gina M Perri, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 10th St Se, Cedar Rapids, IA 52403 Phone: 319-364-7730 | |
Donal Kevin Gordon, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 3rd Ave Se, Cedar Rapids, IA 52403 Phone: 319-730-7300 | |
Mina Soleimani, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Cedar Rapids, IA 52403 Phone: 319-364-7730 Fax: 877-781-3981 | |
Dr. Keri L Mounce, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 777 76th Avenue Dr Sw, Cedar Rapids, IA 52404 Phone: 319-558-0355 Fax: 319-558-0356 | |
Katherine C Arcenas, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1201 3rd Ave Se, Cedar Rapids, IA 52403 Phone: 319-730-7300 | |
Jennifer Lynn Beck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 8th St Se, Cedar Rapids, IA 52401 Phone: 319-398-6170 Fax: 319-398-6466 |